Table 4.
Univariate analysis of predictors of time to discharge between surviving patients
| P value | No. of surviving patients | Time to discharge, median (IQR) | |
|---|---|---|---|
| Sex | 0.16 | ||
| male | 247 | 25 (16–43) | |
| female | 178 | 25 (15–39) | |
| Ward | 0.02 | ||
| medicine | 178 | 22 (15–39) | |
| surgery | 159 | 25 (16–41) | |
| ICU | 88 | 26 (16.5–49.5) | |
| Time to onset of infection (LOC versus EOC) | 0.36 | ||
| EOC (time at risk, ≤10 days) | 112 | 25.5 (14.5–40) | |
| LOC (time at risk, >10 days) | 313 | 25 (16–41) | |
| Comorbidity | |||
| Diabetes mellitus | 0.54 | ||
| yes | 73 | 25 (17–41) | |
| no | 352 | 25 (15–40.5) | |
| COPD | 0.24 | ||
| yes | 126 | 25 (15–46) | |
| no | 299 | 25 (15–39) | |
| Chronic renal failure | 0.09 | ||
| yes | 124 | 28 (16–44.5) | |
| no | 301 | 24 (15–39) | |
| Liver disease | 0.25 | ||
| yes | 30 | 28.5 (16–48) | |
| no | 395 | 25 (15–40) | |
| Solid tumour | 0.51 | ||
| yes | 195 | 25 (15–44) | |
| no | 230 | 25 (15–39) | |
| Haematological malignancy | 0.93 | ||
| yes | 38 | 26 (15–43) | |
| no | 387 | 25 (15–41) | |
| HIV | 0.17 | ||
| yes | 5 | 10 (10–30) | |
| no | 420 | 25 (15.5–41) | |
| Isolated pathogen | |||
| C. albicans | 0.14 | ||
| yes | 244 | 25 (16–43.5) | |
| no | 181 | 23 (15–39) | |
| C. glabrata | 0.55 | ||
| yes | 48 | 26.5 (16–42.5) | |
| no | 377 | 25 (15–40) | |
| C. tropicalis | 0.51 | ||
| yes | 32 | 28 (19–40) | |
| no | 393 | 25 (15–41) | |
| C. parapsilosis | 0.058 | ||
| yes | 89 | 20 (14–38) | |
| no | 336 | 26 (16–41) | |
| Candida krusei | 0.87 | ||
| yes | 7 | 28 (15–38) | |
| no | 418 | 25 (15–41) | |
| Candida guilliermondii | 0.02 | ||
| yes | 3 | 12 (7–13) | |
| no | 422 | 25 (16–41) | |
| other species | 0.43 | ||
| yes | 5 | 26 (13–31) | |
| no | 420 | 25 (15–41) | |
| Polyfungal | 0.30 | ||
| yes | 11 | 25 (20–53) | |
| no | 414 | 25 (15–40) | |
| IIAT | <0.001 | ||
| yes | 54 | 39.5 (22–50) | |
| no | 371 | 24 (15–39) |